BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 6823505)

  • 1. Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors.
    Peterson AV; Prentice RL; Ishimaru T; Kato H; Mason M
    Radiat Res; 1983 Jan; 93(1):184-99. PubMed ID: 6823505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
    Gilbert ES; Ohara JL
    Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of cigarette smoking and radiation exposure to cancer mortality in Hiroshima and Nagasaki.
    Prentice RL; Yoshimoto Y; Mason MW
    J Natl Cancer Inst; 1983 Apr; 70(4):611-22. PubMed ID: 6572749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival analyses of atomic bomb survivors in Hiroshima Prefecture, Japan, 1968-1982--cancer mortality risk among early entrants.
    Matsuura M; Hayakawa N; Shimokata H
    Hiroshima J Med Sci; 1995 Jun; 44(2):29-38. PubMed ID: 7591838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
    Wakabayashi T; Kato H; Ikeda T; Schull WJ
    Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiation risks. Results of the new evaluation].
    Kellerer AM
    Radiologe; 1991 May; 31(5):227-34. PubMed ID: 1876693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced cancer and its modifying factor among A-bomb survivors.
    Kato H
    Princess Takamatsu Symp; 1987; 18():117-24. PubMed ID: 3506538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation exposure and thyroid cancer incidence among Hiroshima and Nagasaki residents.
    Prentice RL; Kato H; Yoshimoto K; Mason M
    Natl Cancer Inst Monogr; 1982; 62():207-12. PubMed ID: 7167191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis.
    Kyoizumi S; Akiyama M; Cologne JB; Tanabe K; Nakamura N; Awa AA; Hirai Y; Kusunoki Y; Umeki S
    Radiat Res; 1996 Jul; 146(1):43-52. PubMed ID: 8677297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological study on lung cancer among A-bomb survivors in Hiroshima.
    Shimizu K
    Hiroshima J Med Sci; 1967 Dec; 16(3):241-53. PubMed ID: 5602854
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80.
    Tokuoka S; Kawai K; Shimizu Y; Inai K; Ohe K; Fujikura T; Kato H
    J Natl Cancer Inst; 1987 Jul; 79(1):47-57. PubMed ID: 3474449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.